Related Experiment Video
Updated: Jun 21, 2026

08:35
Generation of a Three-dimensional Full Thickness Skin Equivalent and Automated Wounding
Published on: February 26, 2015
Human beta defensin-3 engineered keratinocyte sheets constructed by a magnetic force-based tissue engineering
Akira Ito1, Tetsuya Takahashi, Yoshinori Kawabe
1Department of Chemical Engineering, Faculty of Engineering, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan.
Journal of Bioscience and Bioengineering
|August 12, 2009
Summary
Researchers engineered a keratinocyte cell sheet overexpressing the human beta defensin-3 (HBD-3) gene. This genetically modified cell sheet showed strong antimicrobial properties, suggesting a new gene therapy approach for infections.
Area of Science:
- Biomedical Engineering
- Gene Therapy
- Dermatology
Background:
- Infectious diseases pose a significant global health challenge.
- Antimicrobial peptides are crucial components of the innate immune system.
- Developing novel strategies to combat antimicrobial resistance is essential.
Purpose of the Study:
- To engineer a multilayered keratinocyte cell sheet overexpressing the human beta defensin-3 (HBD-3) gene.
- To evaluate the antimicrobial activity of the engineered cell sheet.
- To explore the potential of this approach as a gene therapy for infectious diseases.
Main Methods:
- Magnetic force-based tissue engineering was employed to construct the cell sheet.
- Overexpression of the human beta defensin-3 (HBD-3) gene was achieved in keratinocytes.
- Antimicrobial activity assays were performed to assess efficacy.
Main Results:
- A multilayered keratinocyte sheet successfully overexpressing HBD-3 was prepared.
- The engineered cell sheet exhibited significant antimicrobial activity against relevant pathogens.
- The results demonstrate the feasibility of gene-modified cell sheets for therapeutic applications.
Conclusions:
- The HBD-3 gene-overexpressing keratinocyte sheet holds promise as a novel therapeutic agent.
- This strategy offers a potential new avenue for gene therapy in treating infectious diseases.
- Further research is warranted to translate this finding into clinical practice.

